Tag: Cancer: Pancreatic

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years

Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index

In recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98 percent specificity and 73 percent sensitivity across all stages

Primary end point not met, but small subset of advanced pancreatic ductal adenocarcinoma patients showed durable responses

Increasing incidence mainly due to increased detection of smaller, early-stage endocrine cancer, not adenocarcinoma

Palliative care consultations have no significant impact on the likelihood of documented treatment

Most people erroneously think pancreatic cancer occurs only in older people and that they cannot alter risk

Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor

More than 70 percent with stage I pancreatic ductal adenocarcinoma and about 30 percent with stage II PDAC upstaged after surgery